Sorted By:

Relevance


Edith Mitchell, M.D.

PhRMA  |  Biography

In addition to her medical achievements, Dr.
https://www.phrma.org/biography/edith-mitchell-m-d

DrugFree.org

PhRMA  |  Biography

The Partnership at Drugfree.org works closely with sponsors and supporters, corporate partners, media partners and alliances to develop public education communication campaigns that accomplish their partners’ strategic objectives while enhancing programs to help people live healthy, drug-free lives.
https://www.phrma.org/biography/drugfree-org

Clinical Trials

PhRMA  |  From PhRMA

A clinical trial is a carefully designed study which tests the benefits and risks of a specific medical treatment or intervention, such as a new drug or a behavior change (e.g., diet).Once researchers have completed a rigorous screening and preclinical testing process, the company files an Investigational New Drug (IND) application with the U.S.
https://www.phrma.org/advocacy/research-development/clinical-trials

PhRMA Statement on 2015 Special 301 Report

PhRMA  |  Press Release

We are disappointed USTR chose not to plan an out-of-cycle review (OCR) of India later this year.
https://www.phrma.org/press-release/phrma-statement-on-2015-special-301-report

Gabriela Lavezzari

PhRMA  |  Biography

Prior to Medco, Dr.
https://www.phrma.org/biography/gabriela-lavezzari

America’s Biopharmaceutical Companies Launch Groundbreaking, Multi-Year Initiative Heralding New Era of Medicine

PhRMA  |  Press Release

Revolutionary biopharmaceutical science is the central theme of the campaign advertisements featured at launch.
https://www.phrma.org/press-release/america-s-biopharmaceutical-companies-launch-groundbreaking-multi-year-initiative-heralding-new-era-of-medicine

Director - International Advocacy

PhRMA  |  PhRMA Career

We offer traditional (medical, dental, vision, flexible spending, life, AD&D, LTD, STD, LTC) and enhanced benefits such as parental leave, health advocate service, back-up childcare, commuting and financial & estate planning benefits.
https://www.phrma.org

Industry Profile 2016

PhRMA  |  Report

The annual 2016 Pharmaceutical Industry Profile provides an overview of the sector, highlighting the latest medical advances, the impact of biopharmaceutical companies on the economy and the future of innovation.
https://www.phrma.org/report/industry-profile-2016

Intellectual Property

PhRMA  |  From PhRMA

However, many countries, including nations like Canada, China, and India, embrace IP systems that discourage medical innovation by not providing adequate protections, ultimately diminishing patient access to new treatments and cures.
https://www.phrma.org/advocacy/intellectual-property

Data Exclusivity for Biologics

PhRMA  |  Fact Sheet

Data protection is critical to ensuring continued medical progress, R&D investment, and economic growth.
https://www.phrma.org/fact-sheet/data-exclusivity-for-biologics

Consumers Still Pay Bigger Share For Healthcare Than Government And Businesses

Access Better Coverage  |  From Our Network

And 23% of income for the median household was needed to pay premiums for family coverage in 2013, up from 21% in 2010.
http://www.accessbettercoverage.org/social-news/consumers-still-pay-bigger-share-for-healthcare-than-government-and-businesses

Las Compañías Miembros de PhRMA Invirtieron $58,8 Billones en I&D en 2015

PhRMA  |  Press Release

Desde el año 2000, las compañías miembros de PhRMA han invertido más de medio trillón de dólares en la búsqueda de nuevos tratamientos y curas, incluyendo un estimado de $58,8 billones solo en el 2015.
https://www.phrma.org/press-release/las-compa-as-miembros-de-phrma-invirtieron-58-8-billones-en-iandd-en-2015

PhRMA Statement About Accessing Online Health Information

PhRMA  |  Press Release

“PhRMA hopes that all of the proposals contained in our 16-page submission to the FDA help to inform the Agency’s guidance on how to best communicate the benefits and risks of medicines in new, online media.
https://www.phrma.org/press-release/phrma-statement-about-accessing-online-health-information

I’m Not Average Campaign Hits Close to Home

PhRMA  |  Blog Post

Because of stories like Mema and CJ, medicines should not be evaluated based on the projected value they provide to an average patient, but on the value they provide to individual patients.
http://catalyst.phrma.org/im-not-average-campaign-hits-close-to-home

New First-of-Its-Kind Study Shows Growing Share of Medicine List Prices Going to Rebates and Supply Chain

PhRMA  |  Press Release

View the full BRG study here and an executive summary here.
https://www.phrma.org/press-release/new-first-of-its-kind-study-shows-growing-share-of-medicine-list-prices-going-to-rebates-and-supply-chain

340B Spotlight: 340B hospitals continue to benefit from consolidation at expense of patients

PhRMA  |  Blog Post

Recently, Magellan Rx Management published their 2016 Medical Pharmacy Trend report.
http://catalyst.phrma.org/340b-spotlight-340b-hospitals-continue-to-benefit-from-consolidation-at-expense-of-patients

Medicines in Development for Parkinson's Disease 2014 Report

PhRMA  |  Report

  Understanding Parkinson's Disease: Living, Working & the Economy Each year, approximately 60,000 Americans are diagnosed with Parkinson’s disease, and incidence increases with age.
https://www.phrma.org/report/medicines-in-development-for-parkinson-s-disease-2014-report

Understanding the Drivers of Drug Expenditure in the U.S.

PhRMA  |  Report

The increasing list prices of specific medicines has been widely reported in a series of media events over the past two years, drawing the attention of the public, healthcare stakeholders, and politicians.
https://www.phrma.org

Research in Alabama

PhRMA  |  Research In Your Backyard

Alabama is a leader in medical research, and that supports economic development in our state while also improving lives.
https://www.phrma.org/research-in-your-backyard/research-in-alabama

Chart Pack: Value of Personalized Medicine

PhRMA  |  Report

This chart pack provides facts and figures about the promise of personalized medicine in delivering the right treatment to the right patient at the right dose the first time through the use of molecular biomarker tests and targeted therapies. Data and information found in this publication...
https://www.phrma.org/report/chart-pack-value-of-personalized-medicine

Special Edition Medicare Monday: More context on MedPAC’s analysis of drug costs – Part II

PhRMA  |  Blog Post

There’s an additional factor to consider when assessing the MedPAC data’s implications.
http://catalyst.phrma.org/special-edition-medicare-monday-more-context-on-medpacs-analysis-of-drug-costs-part-ii

Administration’s Special 301 Report highlights deteriorating global environment for biopharmaceutical innovation

PhRMA  |  Blog Post

PhRMA member companies look forward to working with both U.S. and foreign governments to resolve these concerns and to strengthen the global climate for medical innovation.  
http://catalyst.phrma.org/administrations-special-301-report-highlights-deteriorating-global-environment-for-biopharmaceutical-innovation

Medicare Monday: New report highlights progress in fighting cancer with new physician-administered medicines

PhRMA  |  Blog Post

Short-sighted changes to Part B, such as those proposed by the Medicare Payment Advisory Commission (MedPAC), could restrict patients’ ability to access innovative cancer treatments and deter investment in the next generation of cancer medicines.
http://catalyst.phrma.org/medicare-monday-new-report-highlights-progress-in-fighting-cancer-with-new-physician-administered-medicines

Robert Zirkelbach

PhRMA  |  Biography

He oversaw a team responsible for the association’s media relations, public policy communications and grassroots and issue advocacy.
https://www.phrma.org/biography/robert-zirkelbach

Advocacy

PhRMA  |  From PhRMA

PhRMA is committed to advocating for public policies that encourage the discovery and delivery of innovative treatments to patients. From access to medicines and programs like Medicare and Medicaid to intellectual property to drug safety, we work to ensure patient nee...
https://www.phrma.org/advocacy

You have reviewed the first 175 results out of 1046. Each page contains 25 results. You're on page 7.

prev 7 8 9 10 11 12 next